Hepatodoron¿ tablets, 200 pcs
Recalling firm: Weleda Inc
Why it was recalled
Dietary supplement may contain metal
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Dec 13, 2023.
Check your package
Compare the exact product and package details with the label you have.
ProductHepatodoron¿ tablets, 200 pcs
FDA code information
Art.-No. 00326500/003265xx Batch no: J033 Expiry date: January 31, 2027
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Hepatodoron¿ tablets, 200 pcs
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| batch | J033 | Art.-No. 00326500/003265xx Batch no: J033 Expiry date: January 31, 2027 |
| expiration | January 31, 2027 | Art.-No. 00326500/003265xx Batch no: J033 Expiry date: January 31, 2027 |
Original FDA recall reason
Dietary supplement may contain metal
Recall details
- Recall number
- F-0820-2023
- Event ID
- 92052
- FDA status
- Terminated
- Initiated
- Apr 4, 2023
- Reported
- May 10, 2023
- Classified
- May 4, 2023
- Terminated
- Dec 13, 2023
- Quantity
- 890 units
- Location
- Irvington, NY, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
Where it was distributed
nationwide
FDA source record · F-0820-2023
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.